RxDoctor Payments Data

Annette Beasley, MD

Family Medicine · Mayfield, KYNPI 1063504207

Payments from drug & device makers

$585in general payments, 2019–2025

Across 27 payments — averaging $21.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$165
  • Novo Nordisk$136
  • Neurelis, Inc.$82
  • Novartis$35
  • Otsuka America Pharmaceutical, Inc.$28
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$24
  • plus $115 from 6 others

What the payments were for

  • Food & beverage$585100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$585 in reported general payments places this provider in the 45th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$14,588
Medicare patients
103
Services billed
169

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide25$40,927
JardianceEmpagliflozin34$29,575
TrulicityDulaglutide16$22,296
Breztri AerosphereBudesonide/Glycopyr/Formoterol29$19,098
FarxigaDapagliflozin Propanediol12$17,014
MounjaroTirzepatide13$15,132
EliquisApixaban12$11,299
JanuviaSitagliptin Phosphate14$9,528
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$9,279
Albuterol Sulfate HfaAlbuterol Sulfate64$2,241
Estradiol13$1,267
Duloxetine Hcl48$1,214
Gabapentin76$1,043
Losartan Potassium83$887
Methocarbamol23$649

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$136$40,92725 claims
Lilly USA, LLCTrulicity, Mounjaro$19$37,42829 claims
AstraZenecaBreztri Aerosphere, Farxiga$12$36,11341 claims
PfizerEliquis$165$11,29912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Mayfield

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →